|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate, at cost: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and leasehold improvements | ||||||||||||||||||||
| Development and construction in progress | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Accumulated depreciation and amortization | ||||||||||||||||||||
| Real estate, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Investments in U.S. Treasury bills | ||||||||||||||||||||
| Tenant and other receivables | ||||||||||||||||||||
| Receivable arising from the straight-lining of rents | ||||||||||||||||||||
| Deferred leasing costs, net, including unamortized leasing fees to Vornado of $20,044 and $20,649, respectively | ||||||||||||||||||||
| Property held for sale | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Mortgages payable, net of deferred debt issuance costs | ||||||||||||||||||||
| Amounts due to Vornado | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total amounts due to Vornado | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Lease incentive liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock: $1.00 par value per share; authorized, 3,000,000 shares; issued and outstanding, none | ||||||||||||||||||||
| Common stock: $1.00 par value per share; authorized, 10,000,000 shares; issued, 5,173,450 shares; outstanding, 5,107,290 shares | ||||||||||||||||||||
| Additional capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Equity before treasury stock | ||||||||||||||||||||
| Treasury stock: 66,160 shares, at cost | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
